COMMUNIQUÉS West-GlobeNewswire

BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
26/03/2024
CAB-CTLA-4 (BA3071) Phase 1 study cleared dose-limiting toxicity (DLT) observation period with 700 mg (10 mg/kg); initial Phase 2 monotherapy data readout anticipated in 2Q 2024 and in combination with pembrolizumab in [...]
Aptose Reports Results for the Fourth Quarter and Full Year 2023
26/03/2024
Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML Tuspetinib Continues Broad Activity Across Mutations with Excellent Safety Profile Luxeptinib G3 Formulation Achieves Desired Levels and [...]
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28
26/03/2024
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, March 26, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc . (NASDAQ: INMB) (the “Company”), a clinical-stage immunology and [...]
argenx Announces Annual General Meeting of Shareholders on May 7, 2024
26/03/2024
March 26, 2024 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that [...]
Surgery Partners, Inc. Announces Pricing of New Senior Notes Offering
26/03/2024
BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “ [...]
2023 Shareholders General Meeting
26/03/2024
Press release Ecully, March 26, 2024 – 8.00 p.m. Minutes of the General Meeting of March 25, 2024 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Monday, [...]
Assemblée Générale 2023
26/03/2024
Communiqué de presse Ecully, le 26 mars 2024 – 20h Compte-rendu de l’Assemblée Générale du 25 mars 2024 L'Assemblée Générale Mixte (Ordinaire et Extraordinaire) des actionnaires de Spineway s'est tenue sur première [...]
LifeLabs Unveils At Home Kit Program, Empowering Ontarians to Prioritize Health with Ease
26/03/2024
Toronto, Ontario, March 26, 2024 (GLOBE NEWSWIRE) -- LifeLabs, a leading provider of laboratory diagnostic services, is thrilled to introduce our latest offering: At-Home Self-Collection Kits. LifeLabs’ At Home Kit [...]
HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
26/03/2024
The largest prospective registry of its kind will build upon clinical data supporting the use of plaque insights to empower clinical decision making for patients with suspected coronary artery disease MOUNTAIN VIEW, [...]
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas
26/03/2024
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital [...]
Roche receives FDA approval for the first molecular test to screen for malaria in blood donors
26/03/2024
The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria Malaria is a serious and potentially fatal parasitic infection most commonly transmitted by mosquitoes that can [...]
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
26/03/2024
TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Further to the announcement by Psyence Group Inc (" Psyence " or the " Company ") (CSE:PSYG) of its plans for the strategic restructuring of its non-clinical business through [...]
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26/03/2024
MELBOURNE, Australia and SAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease [...]
Hapbee Announces Closing of Private Placement
26/03/2024
Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB [...]
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
26/03/2024
WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on [...]
Grant Christie Joins Acentra Health as Senior Vice President of Market Strategy and Solutions
26/03/2024
MCLEAN, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, [...]
Better Choice Company Initiates Legal Action Against Alphia, a Portfolio Company of Private Equity Firm PAI
26/03/2024
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, initiated a legal action to enforce a right of first refusal [...]
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
26/03/2024
- New patent would extend coverage and expand potential value of Virios’ antiviral pipeline globally – - Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses reactivation - - [...]
Les scientifiques de l’hôpital spécialisé et centre de recherche King Faisal contribuent aux efforts internationaux de lutte contre l’antibiorésistance des bactéries en identifiant une toute nouvelle espèce de bactérie : Riyadhensis
26/03/2024
RIYAD, Arabie saoudite, 26 mars 2024 (GLOBE NEWSWIRE) -- Des scientifiques de l’hôpital spécialisé et centre de recherche King Faisal (ou « KFSH&RC » pour King Faisal Specialist Hospital and Research Centre ) ont [...]

Pages